Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of SVA will remain same at 0 over the next 2 Weeks and hit $6.47 by Friday, March 21, 2025. In that time frame, SVA's share price is expected to range between $6.47 and $6.47.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Mar 21, 2025 | 6.47 | 6.47 | 6.47 |
| Mar 20, 2025 | 6.47 | 6.47 | 6.47 |
| Mar 19, 2025 | 6.47 | 6.47 | 6.47 |
| Mar 18, 2025 | 6.47 | 6.47 | 6.47 |
| Mar 17, 2025 | 6.47 | 6.47 | 6.47 |
| Mar 14, 2025 | 6.47 | 6.47 | 6.47 |
| Mar 13, 2025 | 6.47 | 6.47 | 6.47 |
| Mar 12, 2025 | 6.47 | 6.47 | 6.47 |
| Mar 11, 2025 | 6.47 | 6.47 | 6.47 |
| Mar 10, 2025 | 6.47 | 6.47 | 6.47 |
SVA shares remained flat 0 in Tuesday, February 11, 2025's trading session, starting and closing at a previous close of $6.47 to move at $6.47. The stock demonstrated notable intraday movement (see SVA's key stats for a full breakdown), fluctuating between $6.47 and $6.47, a 0 trading range. While recent weeks have seen some volatility, SVA has managed to secure a 0 no change over the past 2 weeks. The neutral price movement was accompanied by remained steady trading volume, with approximately 0 shares changing hands, 0 fewer than the previous session. This amounted to $0.00 in total market activity.
Will SVA Continue Its Trend?
According to analyst ratings and projections for SVA, Sinovac Biotech Ltd. shares are anticipated to remain stable by 0, potentially reaching $6.47 per share by March 21, 2025. Short-term technical indicators currently suggest a neutral sentiment for SVA. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 0 positive trading days within the past 30 sessions. Based on the SVA stock forecast, now is a good time to buy SVA stock because its current trading price is 0 our predicted value, hinting at a possible . For deeper insights, view our sentiment analysis on SVA covering social and institutional perspectives.
SVA Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into SVA's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 0.00% to 0.00%) suggest the stock is in a strong bearish momentum phase.0Insights into SVA's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Sinovac Biotech Ltd. Monthly Forecast 2025–2026
February 2025
According to our latest forecast models, Sinovac Biotech Ltd. (SVA) is positioned to show a strong performance in February 2025. The price is predicted to move between $26.47 and $26.47, settling at an average of $26.47. This could translate to a +309.12% gain.
March 2025
Based on current market signals, Sinovac Biotech Ltd. is projected to trend march 2025. We forecast a trading range from $26.47 to $26.47, with a likely average price of $26.47. Investors could expect a potential return of +309.12%.
April 2025
Our predictive algorithms indicate Sinovac Biotech Ltd. stock may see a shift in April 2025. The expected range spans $26.47–$26.47, with an average target of $26.47. This represents a positive outlook and a possible gain of +309.12%.
May 2025
Analyzing established trends, Sinovac Biotech Ltd. looks set to move in May 2025. Projections place the stock between $26.47 and $26.47, averaging around $26.47. This suggests a +309.12% gain from current levels.
June 2025
Market indicators suggest Sinovac Biotech Ltd. could experience notable changes during June 2025. Prices could fluctuate within $26.47 to $26.47, with a midpoint forecast of $26.47. The stock might deliver a +309.12% gain.
July 2025
Forecasting for July 2025, models estimate that Sinovac Biotech Ltd. may undergo key fluctuations. If trends hold, the stock might trade between $26.47 and $26.47, averaging $26.47. This signals a positive trajectory with potential returns around +309.12%.
August 2025
According to our latest forecast models, Sinovac Biotech Ltd. (SVA) is positioned to show a strong performance in August 2025. The price is predicted to move between $26.47 and $26.47, settling at an average of $26.47. This could translate to a +309.12% gain.
September 2025
Based on current market signals, Sinovac Biotech Ltd. is projected to trend september 2025. We forecast a trading range from $26.47 to $26.47, with a likely average price of $26.47. Investors could expect a potential return of +309.12%.
October 2025
Our predictive algorithms indicate Sinovac Biotech Ltd. stock may see a shift in October 2025. The expected range spans $26.47–$26.47, with an average target of $26.47. This represents a positive outlook and a possible gain of +309.12%.
November 2025
Analyzing established trends, Sinovac Biotech Ltd. looks set to move in November 2025. Projections place the stock between $26.47 and $26.47, averaging around $26.47. This suggests a +309.12% gain from current levels.
December 2025
Market indicators suggest Sinovac Biotech Ltd. could experience notable changes during December 2025. Prices could fluctuate within $26.47 to $26.47, with a midpoint forecast of $26.47. The stock might deliver a +309.12% gain.
January 2026
Forecasting for January 2026, models estimate that Sinovac Biotech Ltd. may undergo key fluctuations. If trends hold, the stock might trade between $26.47 and $26.47, averaging $26.47. This signals a positive trajectory with potential returns around +309.12%.
February 2026
According to our latest forecast models, Sinovac Biotech Ltd. (SVA) is positioned to show a strong performance in February 2026. The price is predicted to move between $26.47 and $26.47, settling at an average of $26.47. This could translate to a +309.12% gain.
SVA's history of dividends and stock splits also plays a role in long-term investor confidence.

